Canopy acquires Late-Stage applicant for $37mmCHV is a late stage applicant that could see a PLI in the next several months (plus you have 4,000 VET patients), mkt cap of the company is ~$25mm.... I would say its undervalued here.
rTrees just had a pre-license inspection (PLI) last month, but will now wait for Health Canada's response for licensing (assuming no deficiencies), which could occur mid this year. Cultivation license shortly after, and a sales license one year after that, which could yield first revenue in mid-late 2018.